Somewhat Favorable Media Coverage Likely to Impact Exponent (EXPO) Stock Price

Press coverage about Exponent (NASDAQ:EXPO) has been trending somewhat positive on Monday, according to Alpha One Sentiment. Alpha One, a unit of Accern, identifies negative and positive news coverage by monitoring more than twenty million blog and news sources in real-time. Alpha One ranks coverage of public companies on a scale of negative one to one, with scores nearest to one being the most favorable. Exponent earned a media sentiment score of 0.12 on Alpha One’s scale. Alpha One also gave media headlines about the business services provider an impact score of 75 out of 100, meaning that recent news coverage is likely to have an effect on the stock’s share price in the next few days.

Here are some of the news stories that may have effected AlphaOne Sentiment’s rankings:

Insider Buying and Selling by Quarter for Exponent (NASDAQ:EXPO)

Exponent (NASDAQ EXPO) traded up 0.51% during trading on Monday, reaching $59.50. 159,375 shares of the company’s stock were exchanged. The company’s 50-day moving average is $60.36 and its 200-day moving average is $59.48. The company has a market capitalization of $1.54 billion, a PE ratio of 33.07 and a beta of 0.65. Exponent has a 1-year low of $45.00 and a 1-year high of $64.80.

Exponent (NASDAQ:EXPO) last released its quarterly earnings results on Wednesday, April 19th. The business services provider reported $0.39 earnings per share for the quarter, missing the Thomson Reuters’ consensus estimate of $0.48 by $0.09. The company had revenue of $80.47 million during the quarter, compared to analyst estimates of $79.32 million. Exponent had a net margin of 15.41% and a return on equity of 15.47%. The firm’s quarterly revenue was up 1.9% compared to the same quarter last year. During the same quarter last year, the company earned $0.56 EPS. Equities research analysts expect that Exponent will post $1.84 earnings per share for the current fiscal year.

The business also recently declared a quarterly dividend, which will be paid on Friday, June 23rd. Stockholders of record on Friday, June 9th will be issued a $0.21 dividend. This represents a $0.84 annualized dividend and a dividend yield of 1.41%. The ex-dividend date of this dividend is Wednesday, June 7th. Exponent’s dividend payout ratio (DPR) is presently 46.67%.

Several brokerages have weighed in on EXPO. Zacks Investment Research downgraded Exponent from a “buy” rating to a “hold” rating in a report on Wednesday, April 19th. Cantor Fitzgerald restated an “overweight” rating and set a $69.00 price objective (up from $64.00) on shares of Exponent in a report on Saturday, April 22nd.

WARNING: “Somewhat Favorable Media Coverage Likely to Impact Exponent (EXPO) Stock Price” was originally published by BBNS and is the sole property of of BBNS. If you are accessing this article on another website, it was illegally copied and republished in violation of US and international trademark and copyright legislation. The original version of this article can be read at https://baseballnewssource.com/markets/exponent-expo-receives-media-impact-rating-of-0-12-updated/985437.html.

Exponent Company Profile

Exponent, Inc (Exponent), along with its subsidiaries, is a science and engineering consulting company. Exponent provides engineering and scientific consulting services to clients around the world. Its service offerings are provided on a project-by-project basis. It operates in two segments: Engineering and Other Scientific, and Environmental and Health.

Receive News & Ratings for Exponent Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Exponent Inc. and related companies with our FREE daily email newsletter.

 


Latest News

Hitters in Major League Baseball on Record Home Run Pace
Hitters in Major League Baseball on Record Home Run Pace
Atlanta Considering Playing Freddie Freeman at Third
Atlanta Considering Playing Freddie Freeman at Third
Injury to Gleyber Torres Adds to Questions About Yankees
Injury to Gleyber Torres Adds to Questions About Yankees
Game Winning Home Run Completes Nolan Arenado Cycle
Game Winning Home Run Completes Nolan Arenado Cycle
New York Yankees and Masahiro Tanaka Hit Hard Again
New York Yankees and Masahiro Tanaka Hit Hard Again
Victor Martinez Diagnosed with Irregular Heartbeat
Victor Martinez Diagnosed with Irregular Heartbeat


Leave a Reply

 
© 2006-2017 BBNS.